Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 9,048 | -14,207 | -9,105 | -5,497 | -3,213 |
| Depreciation Amortization | 1,022 | 3,719 | 2,718 | 1,782 | 885 |
| Accounts receivable | -14,167 | -3,361 | -1,375 | -2,060 | 790 |
| Other Working Capital | -2,588 | -5,674 | -3,873 | -4,879 | 1,338 |
| Other Operating Activity | 11,667 | 300 | 1,812 | 2,489 | -671 |
| Operating Cash Flow | $4,982 | $-19,223 | $-9,823 | $-8,165 | $-871 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -13,920 | N/A |
| PPE Investments | -2,025 | -4,402 | -3,063 | -1,125 | -698 |
| Investing Cash Flow | $-2,025 | $-4,402 | $-3,063 | $-15,045 | $-698 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -689 | 4,592 | 2,092 | 2,675 | 2,722 |
| Debt Repayment | -267 | -993 | -674 | -412 | -163 |
| Common Stock Issued | 1,985 | 25,312 | 23,731 | 23,601 | 15 |
| Financing Cash Flow | $1,029 | $28,911 | $25,149 | $25,864 | $2,574 |
| Beginning Cash Position | 15,505 | 10,219 | 10,219 | 10,219 | 10,219 |
| End Cash Position | 19,491 | 15,505 | 22,482 | 12,873 | 11,224 |
| Net Cash Flow | $3,986 | $5,286 | $12,263 | $2,654 | $1,005 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,982 | -19,223 | -9,823 | -8,165 | -871 |
| Capital Expenditure | -2,025 | -4,402 | -3,063 | -1,125 | -698 |
| Free Cash Flow | 2,957 | -23,625 | -12,886 | -9,290 | -1,569 |